How to Use the Wegovy Pen for Best Results with Guidance for Bishops Stortford Patients

The Wegovy pen, known as the FlexTouch, is a pre-filled multi-dose device containing four once-weekly doses of semaglutide. Knowing how to use it correctly from the very first injection is one of the most important steps any patient can take towards getting the best possible results from their treatment. Unlike some injectable devices, the Wegovy FlexTouch requires a new compatible disposable needle to be attached before each injection. The needle must be removed and disposed of safely in a sharps container immediately afterwards, before the pen is stored for the next weekly dose. After the fourth and final weekly injection from each pen, the pen is disposed of in accordance with local guidance and a new pen is used for the following four weeks of treatment. Always follow the Instructions for Use supplied with your specific pen, as these contain the authoritative guidance for your device and dose and must take precedence over any general information. The clinical team at J E Williamson Pharmacy in Bishops Stortford makes certain that no Wegovy patient administers their first dose without first receiving the thorough, personalised pen training that gives correct technique and complete confidence from the very start of treatment.

Getting to Know the Wegovy FlexTouch Pen

Before the first injection, spending a few minutes familiarising yourself with the Wegovy FlexTouch pen and how it works makes every subsequent weekly injection more straightforward and less daunting. The pen is a pre-filled multi-dose device available in five dose strengths corresponding to the Wegovy titration schedule: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg. Each pen is colour-coded by dose strength, making it straightforward to identify the correct pen for the current stage of treatment and reducing the risk of dose errors. The pen has a clear viewing window that allows you to inspect the liquid before each injection. For specific guidance on how to administer each dose correctly using the FlexTouch pen, including how to use the dose button and confirm full delivery, always follow the Instructions for Use supplied with your specific device. Pen needles are not included with the FlexTouch pen and must be obtained separately from your prescribing pharmacy. Your pharmacy can advise on the compatible needle type and ensure you have an adequate supply before you begin treatment.

A new needle must be attached to the pen immediately before each of the four weekly injections and removed and disposed of in a sharps container directly after each use. Never leave a needle attached to the pen between injections, as this poses a safety risk and may allow air or other substances to enter the pen cartridge. The pen is never discarded after a single injection. Instead it is recapped and stored safely until the next weekly dose. After the fourth and final weekly injection from any given pen, the pen is disposed of in accordance with local waste guidance. Your prescribing pharmacy can advise on the most appropriate disposal method in your area, and in many areas filled sharps containers can be returned to a pharmacy for safe disposal free of charge.

Storing the Wegovy Pen Correctly

Correct storage of the Wegovy FlexTouch pen between injections is essential for maintaining the medication’s safety and potency throughout its four-dose lifespan. Unused pens should be stored in their original packaging in a refrigerator at 2 to 8 degrees Celsius, away from the freezer compartment. A pen that has been frozen must not be used, as freezing may damage the medication. Always contact your prescribing pharmacy for a replacement rather than using a pen that has been exposed to freezing temperatures. The Instructions for Use supplied with your pen specify any additional storage guidance applicable to your specific dose and formulation, including how long the pen may be kept outside the refrigerator between injections. Always defer to these instructions rather than general guidance, as requirements may vary.

Keep pens in their original outer packaging to protect them from light and physical damage, and never store them where temperature control cannot be reliably maintained. If travelling with Wegovy, carry the pen in an insulated cool bag and confirm the travel storage requirements with your prescribing pharmacist in advance. Keep all pens, needles, and the sharps container out of the sight and reach of children and pets at all times, and ensure your sharps container is accessible before each weekly injection session.

Inspecting the Pen Before Every Injection

A brief but important inspection should be carried out before each of the four weekly injections to confirm the pen is safe and appropriate to use. Check the expiry date on the pen label and never use a pen that has passed it. Look through the viewing window at the liquid inside. It should be clear or colourless and completely free of particles, cloudiness, or any visible sediment. Do not inject if the liquid looks different from this description. Contact your prescribing pharmacy for guidance and a replacement pen if the liquid appears abnormal in any way. Check that the pen body is intact and undamaged. If the pen has been dropped, it may have sustained damage that is not externally visible. When in doubt, contact your pharmacy for advice before proceeding with an injection rather than using a potentially compromised device. Do not use a pen from which a needle has been left attached since the previous injection, as needles must always be removed and disposed of immediately after each use.

Attaching a New Needle

Attaching a new compatible disposable needle to the Wegovy FlexTouch pen is a required step before every weekly injection and should be carried out by following the specific instructions set out in the Instructions for Use supplied with your pen. Never reuse a needle from a previous injection. Needles become blunt after a single use and reusing them increases the risk of injection site complications, inaccurate dose delivery, and infection. The attachment and removal process is described in full in the Instructions for Use and should be followed precisely each time. If you are uncertain about any part of the needle attachment process at any stage of your treatment, contact your prescribing clinician or pharmacist for guidance before proceeding with your next injection.

Choosing and Changing Your Injection Site

Wegovy is approved for subcutaneous injection at three anatomical sites: the abdomen, the front of the upper thigh, and the outer upper arm. When using the abdominal site, the injection should be placed at least 5cm away from the navel, as the skin in this area tends to be structurally different in ways that can affect absorption. All three sites are clinically equivalent in terms of semaglutide absorption when the injection is performed correctly. The most important practical consideration is not which site you choose but that you change the site each week and vary the specific injection point within each site over time. Changing the injection site each week prevents repeated trauma to any single area of skin and subcutaneous tissue. This can otherwise lead to tissue changes that impair drug absorption throughout the full course of treatment.

The abdominal site is the most commonly chosen option due to its large surface area and ease of access, and it is often the most comfortable choice for patients who are new to self-injection. The front of the upper thigh is a practical alternative that is particularly well-suited to patients who prefer to inject while seated. The outer upper arm can be used and is equally effective clinically, but is more difficult to access without assistance and is generally better suited to patients who have a carer or partner who helps with the weekly injection. Never inject into skin that is bruised, red, irritated, or hardened. If you notice any lumps, unusual firmness, or changes in texture at any injection site, avoid that area and report it to your prescribing clinician or pharmacist promptly. Injection site changes can have several causes and should always be assessed clinically rather than managed independently.

Using the Wegovy Pen Step by Step

The specific steps for administering each weekly Wegovy injection are set out in the Instructions for Use supplied with your medication, and these should always be your primary reference for every injection throughout the pen’s four-dose lifespan. As a general overview, the process involves inspecting the pen and liquid, attaching a new compatible needle, selecting and preparing the injection site, positioning the pen correctly against the skin, and delivering the dose as described in the Instructions for Use. Always use these device-specific indicators to confirm successful administration rather than any general guidance from secondary sources, which may not accurately reflect the specific device and dose you are using.

After confirming the dose has been delivered, remove the needle from the pen as directed and place it immediately into the sharps container. The pen is then recapped and stored correctly for the following week’s injection. If something does not seem right, the pen does not respond as expected, or you are uncertain whether the full dose has been delivered, do not attempt a second injection without first speaking to your prescribing pharmacy or clinician. Administering more than the prescribed weekly dose significantly increases the risk and severity of side effects and should be avoided under all circumstances.

Managing the Dose Titration Schedule

A clear understanding of the Wegovy titration schedule and which pen strength corresponds to each stage of treatment is one of the most practical tools any patient has for managing their treatment confidently and keeping dose errors firmly out of the picture. The titration schedule begins at 0.25mg once weekly and progresses through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. Each dose level is maintained for a minimum of four weeks before escalation. The titration schedule can be extended at any level if tolerability requires it, and this is a clinical decision to be made with your prescribing clinician rather than independently. Each pen strength is clearly labelled and colour-coded, making it straightforward to identify the correct pen for each stage. When transitioning to a new dose strength, always confirm with your prescribing pharmacy or clinician that you have the correct pen before administering the first injection at that level.

The 0.25mg starting dose is a sub-therapeutic adjustment dose designed to allow the body to adapt to the medication rather than a dose at which significant weight loss is expected. Patients who assess their results during the first four to eight weeks of treatment are doing so at a point when the medication has not yet reached a therapeutic weight loss dose. The most meaningful weight loss associated with Wegovy in clinical trials occurs from around week 16 onwards, once patients are established at or near the 2.4mg maintenance dose. Patience and consistency through the titration phase are among the most important contributions any patient can make to their long-term treatment outcomes.

What to Do if You Miss a Weekly Dose

Wegovy should be administered on the same day each week at any time of day, with or without food. Choosing an injection day that fits reliably and consistently into your weekly routine is the most effective way to ensure on-schedule dosing throughout your treatment. If you miss your scheduled injection day, you can administer the missed dose up to five days late, provided your next scheduled injection day is more than two days away. If your next scheduled dose falls within two days of when you would administer the late dose, skip the missed dose entirely and resume your regular weekly schedule on your next scheduled day. If more than five days have passed since your scheduled injection day, skip that week’s dose entirely. Resume your injection on your next regularly scheduled day, maintaining the same weekly interval throughout. Never administer two doses close together to compensate for a missed injection. If you are unsure whether it is appropriate to administer a late dose, contact your prescribing pharmacy or clinician before proceeding.

With your weekly injection routine in place, understanding what Wegovy could realistically deliver for your individual starting point is one of the most motivating pieces of the picture.  Enter your height and weight into our calculator below to find out how much you could potentially lose with Wegovy or Mounjaro:

Recognising and Responding to Adverse Effects

The most commonly reported side effects of Wegovy are gastrointestinal in nature, including nausea, vomiting, diarrhoea, and constipation, and are typically most pronounced in the first few weeks at each new dose level before improving as the body adjusts. Minor injection site reactions such as brief localised stinging, mild redness, or small amounts of bruising are also common and generally resolve within a day or two without any intervention. More significant injection site reactions including persistent or spreading redness, increasing swelling, warmth, or any discharge should be reported to a clinician promptly as they may require assessment and treatment. Signs of pancreatitis, in particular severe and persistent abdominal pain including pain that radiates to the back, require urgent medical attention. Do not wait for a scheduled appointment if you experience these symptoms. Report any significant or unexpected symptoms to your prescribing clinician or pharmacist as soon as they arise rather than waiting to see whether they resolve independently.

Frequently Asked Questions

From needle attachment to missed doses, here are the Wegovy pen questions that come up most consistently in consultations with the clinical team at J E Williamson Pharmacy in Bishops Stortford at every stage of treatment.

Does the Wegovy pen come with needles?

Pen needles are not included with the Wegovy FlexTouch pen and must be obtained separately. Your prescribing pharmacy can advise on the compatible needle type for your pen and ensure you have an adequate supply before you begin treatment, so that a new needle is available for each of the four weekly injections.

How many injections does one Wegovy pen give?

Each Wegovy FlexTouch pen contains four once-weekly doses of semaglutide at the prescribed strength, meaning one pen covers four weeks of treatment before it needs to be replaced with the next pen. After the fourth and final weekly injection, the pen should be disposed of in accordance with local guidance even if liquid appears to remain in the viewing window.

Can I leave the needle attached to the Wegovy pen between injections?

No. The needle must be removed from the pen and disposed of in a sharps container immediately after each injection and must never be left attached between uses. Leaving a needle attached poses a needle-stick injury risk and may allow air or other substances to enter the pen cartridge, potentially affecting the accuracy of subsequent doses.

How do I know the Wegovy pen has delivered the full dose?

The Instructions for Use supplied with your specific Wegovy FlexTouch pen describe the indicators that confirm a full dose has been successfully delivered. Always use these device-specific indicators to confirm administration rather than relying on general secondary sources, and if you have any doubt about whether the full dose was delivered, contact your prescribing pharmacy or clinician before taking any further action.

Can I change the day I give my Wegovy injection?

Yes, the injection day can be changed if needed, provided the new day is at least two days after your most recent injection, after which the standard weekly seven-day interval should be maintained going forward. Once changed, keeping the new day consistent each week supports a stable and predictable dosing pattern throughout your treatment.

What should I do if the Wegovy pen does not activate correctly?

If the pen does not respond as expected or you are uncertain whether the dose has been delivered correctly, do not attempt a second injection from the same or a new pen without first contacting your prescribing pharmacy or clinician for guidance. Administering more than the prescribed weekly dose significantly increases the risk and severity of side effects and must be avoided under all circumstances.

Use the Wegovy Pen With Confidence

Learning how to use the Wegovy FlexTouch pen correctly is one of the most practical and empowering steps any patient can take at the start of their weight loss treatment. This means attaching and removing needles safely, inspecting the pen before every use, changing the injection site each week, following the Instructions for Use, and disposing of needles and the pen correctly. With the right guidance and a little practice, the weekly injection becomes a quick and routine part of the week, and every correctly administered dose of semaglutide gives the medication the very best opportunity to deliver the meaningful, lasting results it is clinically proven to produce. Wegovy treatment at J E Williamson Pharmacy in Bishops Stortford means having an expert clinical team behind you at every stage. From mastering the FlexTouch pen on day one to achieving lasting weight loss results, our team provides the personalised care and commitment to patient safety that elevates good treatment into something truly transformative. Book now and start your Wegovy journey with the injection knowledge, clinical confidence, and expert support you deserve from day one.